Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

Howard James F. and Utsugisawa Kimiaki and Benatar Michael and Murai Hiroyuki and Barohn Richard J. and Illa Isabel and Jacob Saiju and Vissing John and Burns Ted M. and Kissel John T. and Muppidi Srikanth and Nowak Richard J. and O'Brien Fanny and Wang Jing-Jing and Mantegazza Renato and Vécsei László (kollab. közrem.): Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study.
LANCET NEUROLOGY, 16 (12). pp. 976-986. ISSN 1474-4422 (2017)

[thumbnail of 2017._Howard_J._Safety_and_efficacy_of_eulizumab__Lancet_Neur._u.pdf] Text
2017._Howard_J._Safety_and_efficacy_of_eulizumab__Lancet_Neur._u.pdf - Published Version
Closed access: Repository staff only

Download (568kB) | Request a copy
Item Type: Journal Article
Szerzők száma: 609
Journal or Publication Title: LANCET NEUROLOGY
Date: 2017
Volume: 16
Number: 12
Page Range: pp. 976-986
ISSN: 1474-4422
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3298840
DOI azonosító: https://doi.org/10.1016/S1474-4422(17)30369-1
Date Deposited: 2018. Jan. 16. 12:48
Last Modified: 2020. Feb. 18. 15:54
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12702
Web of Science® Times Cited: 352 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year